Company / Cost of Revenue
Warby Parker Inc. Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$401.3M
FY2025
5-year range
$147.4M / $401.3M
FY2021-FY2025
Trend
+16.5%
vs FY2024
Sector context
#72 of 113
Health Care
What the data says
At $401M, Warby Parker Inc.'s cost of revenue ranks #42 of 113 in the Health Care sector. Cost of Revenue has increased for 4 consecutive years, from $147M in FY2021 to $401M in FY2025.
Based on SEC 10-K filings.
$401M in FY2025 with a 5-year CAGR of +19.9%.
Increased from $305M to $401M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +35.4%
- 5-Year CAGR
- +19.9%
- 10-Year CAGR
- -
Sector benchmark
#42 of 113 in Health CareTop 36% of 113This company $401.3M Sector average $11.3B
▼
-96.4% below sector average
Key checks
Key Insights
- Warby Parker Inc.'s cost of revenue has grown for 4 consecutive years.
- 5-year CAGR of +19.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 16.5% year-over-year.
- Ranks #72 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $401.3M | +16.5% |
| FY2024 | $344.5M | +13.1% |
| FY2023 | $304.5M | +88.2% |
| FY2022 | $161.8M | +9.8% |
| FY2021 | $147.4M | -8.9% |
| FY2020 | $161.8M | +9.8% |
| FY2019 | $147.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026